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Aim: Our aim was to investigate the usefulness of serum interleukin-8 (IL-8) and the neutrophil-to-lymphocyte ratio (NLR), either by
themselves or as adjuncts to CA-125, in the diagnosis of various stages of endometriosis.
Materials and methods: This study was a single-centre, prospective, group-comparative clinical trial. Serum IL-8 and the NLR, either
alone or as adjuncts to CA-125, were analysed using receiver-operating characteristic (ROC) analysis to diagnose endometriosis. Fifty
patients with endometriosis and 50 patients with benign ovarian cysts were included in this study.
Results: The overall sensitivity and specificity of the combined markers for the detection of endometriosis were 80.0% and 86.0%,
respectively, when using a cut-off value of 43.1. The mean NLR, IL-8, and combined marker in patients with minimal to mild
endometriosis were significantly higher than in patients without endometriosis, but the mean CA-125 was not.
Conclusion: Measurements of NLR and the combined marker may be used as simple and easily obtained diagnostic markers for
endometriosis.
Key words: Endometriosis, interleukin-8, CA-125, neutrophil-to-lymphocyte ratio

1. Introduction
Defined by the presence of endometrial-like cells outside
the uterus, endometriosis is a major cause of pelvic pain,
dysmenorrhoea, dyspareunia, infertility, and menstrual
irregularities affecting 5%–10% of reproductive-aged
women (1).
There is often a delay of several years before a diagnosis
of endometriosis is made, mainly due to the nonspecific
and variable nature of the associated symptoms and the
need to verify the disease surgically. Biological markers
such as interleukins and CA-125 have been widely used
as well-described markers of endometriosis. However,
these tests have not yielded sufficient power to diagnose
the initial stages of endometriosis, and they have low
sensitivity and specificity compared with laparoscopy (2).
Therefore, there is a need for a reliable diagnostic
marker of endometriosis, especially in the early stages of
peritoneal disease when imaging is not effective and CA125 is not specific. Such a marker or panel of markers
should be noninvasive, specific for endometriosis, and
sensitive in all stages and locations of the disease, and it
should not be affected by the timing of blood collection.
* Correspondence: sudesarikaya@hotmail.com

Many new biological markers have been described in
the serum, peritoneal fluid (PF), urine, and endometrial
tissue, but they are still in the early stages of development,
and no validation trials have been carried out to assess
their use as reliable means of diagnosing endometriosis
in a clinical setting (3). Therefore, researchers are now
returning to combinations of known biochemical markers
and advanced statistical analysis to predict cases of
endometriosis (4–9).
The need to identify a reliable, noninvasive marker
of endometriosis has led researchers to consider the
pathogenesis of endometriosis, in which immunological
factors and angiogenesis seem to play a key role.
Endometriosis may be viewed as a local disease with a
systemic, subclinical inflammation process that involves
changes in the relative levels of circulating white blood
cells (WBCs); neutrophilia is accompanied by relative
lymphocytopenia and an increase in serum proteins such
as C-reactive protein (CRP) (10,11).
These observations and an extensive literature search
led to the design of the current study, which investigates
the usefulness of analysing serum interleukin-8 (IL-8)
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and the neutrophil-to-lymphocyte ratio (NLR), either by
themselves or as adjuncts to CA-125, in the diagnosis of
endometriosis.
2. Materials and methods
2.1. Setting of the study
This single-centre, prospective, group-comparative
clinical trial was conducted between March 2009 and
August 2009 at the Zekai Tahir Burak Women’s Health
Education and Research Hospital in Ankara, Turkey.
The local ethics committee approved the study, and the
participating subjects signed a consent form. The 100
subjects included in the present study were recruited
from 110 Caucasian women of reproductive age who were
scheduled to undergo laparoscopy or laparotomy during
the early follicular phase because of clinical indications of
tubal ligation, benign ovarian cysts, infertility, or pelvic
pain. Each patient’s menstrual cycle phase was determined
based on her last period.
Cases were defined by the presence of endometriotic
lesions that were confirmed during surgical examination
and a subsequent pathological evaluation. The
gynaecologists collaborating in the study were trained
surgeons who were skilled at detecting and identifying all
forms of endometriotic lesions. For those patients with
endometriosis, the extent of the disease was determined
using the American Society of Reproductive Medicine
(ASRM) revised classification (12).
In a consultation with statisticians, it was advised that
40 patients with endometriosis and 40 women without
the disease were needed to detect a clinical difference
of at least 0.2 between the areas under the receiveroperating characteristic (ROC) curve of each diagnostic
test with a significance level (α) of 0.05 and a power of
0.8 (β = 0.2). Inflammatory processes, age, sex, body mass
index (BMI), alcohol intake, cigarette smoking, and oral
contraceptive use affect CRP levels and the proportion
and function of blood leukocytes. Therefore, the exclusion
criteria included the use of hormonal medications during
the 6 months prior to the laparoscopy, a presentation of
ovarian neoplasia or pelvic inflammatory disease (PID)
as an intraoperative finding, pregnancy, the presence
of acute or chronic inflammation and autoimmune
disease, or the refusal to participate. In addition, patients
with pathological confirmation or clinical suspicion of
leiomyoma or adenomyosis leading to increased CA125 levels were also excluded. As a result, 10 patients
were excluded from the study due to cigarette smoking
(2 patients), the concomitant presence of myomas (4
cases), and PID (4 cases). In the end, a total of 50 women
with surgically and histologically confirmed stage I–IV
endometriosis were selected as the study group, and
50 women who were surgically confirmed to be free of
endometriosis were selected as the control group.
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Prior to surgery, the demographic characteristics,
smoking status, drug intake, and past medical and
reproductive history of each woman were obtained.
Peripheral venous blood samples were collected for a
routine full blood count and CRP, IL-8, and CA-125 levels.
The samples were centrifuged, and the resulting sera were
then frozen at –80 °C until assayed.
2.2. Definitions
The NLR was defined as the absolute neutrophil count
divided by the absolute lymphocyte count. The combined
marker values were obtained by multiplying CA-125 levels
by the NLR.
2.3. Laboratory analysis
Standard CRP levels were measured by an
immunoturbidimetric assay (Hitachi 917/Tina Quant,
Roche Diagnostics, Mannheim, Germany), and
concentrations were expressed as mg/L. The analytical
sensitivity of the assay was 0.03 mg/L (intra- and
interassay coefficient of variations [CVs] = 0.2% and
2.5%, respectively). Serum CA-125 levels were measured
using the CA-125 II assay (ADVIA Centaur, Siemens, Los
Angeles, CA, USA), and concentrations were expressed
as IU/mL. The analytical sensitivity of the test is 2 U/mL,
with a high specificity for CA-125. The intraassay error
of this assay was 4.03%. The plasma concentrations of
IL-8 were determined using IMMULITE 1000 (Siemens),
and concentrations were expressed as pg/mL. This assay
exhibited an intraassay CV of 2.5%, an interassay CV of
4.5%, and a sensitivity of 0.7 pg/mL (LD = 10 pg/mL, intraand interassay CVs of <15% and <30%, respectively).
2.4. Statistical analysis
The data are presented as either the median (range) or
mean ± standard deviation as appropriate. All of the
variables were tested for normal distribution with the
Kolmogorov–Smirnov test, histograms, and P–P plots.
The differences between the means of the groups were
compared with either Student’s t-test or the Mann–
Whitney U test, depending on the normality of the data.
The Kruskal–Wallis test was used to compare variables
between more than 2 groups, and the percentage of patients
with abnormally elevated values was analysed using
the chi-square test. The correlations between or within
groups were evaluated with the Pearson or Spearman rank
correlation coefficient, where appropriate. To compare
the usefulness of CA-125, NLR, IL-8, and the combined
markers in diagnosing endometriosis, we examined the
ROC curve. SPSS 12.0 (SPSS Inc., Chicago, IL, USA) was
used for statistical analysis, and P < 0.05 was considered
statistically significant.
3. Results
The baseline characteristics of patients with and without
endometriosis are shown in Table 1.
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Table 1. Characteristics of the study group.
Variables
Age (years)
Gravida
Parity
BMI
Operation

Laparotomy
Laparoscopy

Endometriosis
(n = 50)

Control
(n = 50)

26.8 ± 6.2
0.57 ± 0.86
0.56 ± 0.81
23.21 ± 0.76

27.4 ± 7.2
0.86 ± 1.1
0.60 ± 0.88
21.22 ± 0.23

13 (26%)
37 (74%)

0 (0%)
50 (100%)

Pa
0.820
0.432
0.874
0.765

Mann–Whitney U test.

a

Three patients had stage I, 15 patients had stage II,
24 patients had stage III, and 8 patients had stage IV
endometriosis. Other benign gynaecological pathologies
concomitantly observed in 14 patients were: ovarian
dermoids (2 cases), seromucinous ovarian cysts (5 cases),
paraovarian cysts (3 cases), and pelvic pain (5 cases).
The patients with endometriosis had significantly
higher WBC levels (8.112 versus 7.110, P < 0.05), neutrophil
counts (5872 versus 4563, P < 0.05), NLRs (4.2 versus 2.82,
P < 0.05), combined markers (232 versus 42.90, P < 0.05),

CA-125 levels (53.53 IU/mL versus 13.7 IU/mL, P < 0.05),
and IL-8 levels (561.81 versus 96.38, P < 0.05) than the
control patients. In contrast, the lymphocyte count was
significantly lower in patients with endometriosis than
in control patients (1601.86 versus 1964.22, P < 0.05).
Conversely, the women with and without the disease were
shown to have similar levels of CRP, monocyte counts,
eosinophil counts, and basophil counts. These results are
illustrated in Table 2.

Table 2. Comparison of WBCs and subtypes, NLR, CA-125, IL-8, and micro-CRP mean, minimum, and
maximum values between groups.

WBCs/mLb
Neutrophils/mL
Lymphocytes/mL
Monocytes/mL
Eosinophils/mL
Basophils/mL
NLRc
Combined marker

d

CA-125 IU/mL
IL-8 pg/mL
CRP
a

Endometriosis
(n = 50)

Control
(n = 50)

8112.00
(4800.00–17,600.00)
5872.18
(2568.00–15,488.00)
1601.86
(500.00–2937.00)
485.08
(125.00–831.00)
139.82
(16.00–1521.00)
33.82
(00–76.00)
4.2
(1.24–11.49)
232.94
(26.94–1750.34)
53.53
(13.48–200.6)
561.81
(5.17–7500)
3.57
(0.3–27.66)

7110.00
(5100.00–17,800)
4563.00
(2204.00–17,800.00)
1964.22
(713.00–3267.00)
442.74
(33.00–774.00)
106.12
(16.00–366.00)
26.98
(0.00–59.00)
2.82
(0.87–13.75)
42.90
(8.12–273.70)
13.17
(5.03–40.10)
96.38
(2–844)
1.79
(0.21–10.85)

Pa
<0.05
<0.05
<0.05
0.061
0.196
0.120
<0.05
<0.05
<0.05
<0.05
0.101

Mann–Whitney U test. Values are expressed as means.
WBCs: White blood cells, cNLR: neutrophil-to-lymphocyte ratio, dserum CA-125 levels multiplied by NLR.

b
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The ROC analysis revealed that the area under the
curves for the WBCs, NLRs, CA-125, combined markers,
and IL-8 were statistically significant for women who
were diagnosed with endometriosis (P < 0.05) (Table 3).
The diagnostic performance of CA-125 was assessed at a
cut-off point of 29.9 IU/mL, NLR was assessed at a cutoff point of 2.19, neutrophil count was assessed at a cutoff value of 4058, and combined markers were assessed
at a cut-off value of 43.1. The combined markers had the
highest area under the curve and demonstrated the highest
sensitivity (80.0%) and a fairly good specificity (86.0%) for
the detection of endometriosis (Figure).
Table 4 provides the mean levels of IL-8, NLR, CA-125,
and the combined markers, in addition to a comparison
of percentages of the disease detection rates of each
parameter at various stages of endometriosis. The highest
mean values for all 4 markers were found in patients at
stage IV.
For the patients with minimal to mild endometriosis
(Stage I + II), the difference in the percentage of disease
detection rates of CA-125 was statistically significantly
lower (33%) than that of the combined marker (66.6%),
NLR (61.1%), and IL-8 (55.5%) (P < 0.005). Although
there were no significant differences between the other
markers, the combined marker and NLR seem to have
better diagnostic value than other markers for patients
with minimal to mild endometriosis. However, for Stage I
endometriosis, which is the group that many clinicians are
most interested in, the most effective marker seems to be
NLR (66.6%), and for Stage II endometriosis, it seems to be
the combined marker (73.3%). For patients with moderate
to severe disease (Stage III + IV), the disease detection rate
of the combined marker (87.5%) was significantly higher

than that of IL-8 (65.6%) (P < 0.005). In this group, the
differences between the percentages of disease detection
rates of NLR (84.3%), CA-125 (81.2%), and the combined
marker (87.5%) levels were not statistically significant and
were fairly good (Table 4).
When the correlations between the stage of the disease
and the levels of serum IL-8, CA-125, NLR, and the
combined markers were evaluated, significant correlations
between the stage of the disease and the serum NLR or
combined marker levels were noted (r = 0.448 and r =
0.341, respectively; P < 0.005). No significant correlation
between disease stage and IL-8 or CA-125 levels was
found (r = 0.240 and P = 0.094, r = 0.218 and P = 0.128,
respectively).
4. Discussion
Changes in the WBC populations of the peripheral blood,
endometrium, and PF have previously been reported in
women with endometriosis. In addition, it has also been
shown that NLR has no significant menstrual-phase–
specific differences, unlike CA-125 and interleukins (13–
20). Recently, WBC subtypes and the NLR have started
to be used frequently as simple indices of the systemic
inflammatory response in critically ill patients and as
prognostic indicators for various cancers and diseases
(21–24). However, the clinical value of differential WBC
counts and the NLR, either by themselves or as adjuncts
to CA-125, has been suggested recently as a diagnostic test
for endometriosis only in a single retrospective study (8).
The authors of that study found that using a CA-125 cutoff point of 35 IU/mL provided a 55.8% sensitivity and a
92.8% specificity. A NLR cut-off of 2.01 gave a sensitivity
and specificity of 60%. Furthermore, the combined

Table 3. Diagnostic sensitivity and specificity of the NLR, CA-125, IL-8, and WBC subtypes in endometriosis patients.
AUCa
(95% CIb)
WBCs/mLc
Neutrophils/mL
NLRd
Combined markere
CA-125 IU/mL
IL-8 pg/mL

0.574
(0.507–0.641)
0.615
(0.572–0.658)
0.751
(0.648–0.854)
0.817
(0.754–0.880)
0.772
(0.752–0.792)
0.703
(0.600–0.806)

Sensitivity
(%)

Specificity
(%)

Cut-off
value

P

64.0

54.0

6400

<0.05

68.0

60.0

4058

<0.05

76.0

82.0

2.19

<0.05

80.0

86.0

43.1

<0.05

64.0

88.0

29.9

<0.05

62.0

73.0

24

<0.05

AUC: Area under curve, bCI: confidence interval, cWBCs: white blood cells, dNLR: neutrophil-to-lymphocyte ratio, eserum CA-125
levels multiplied by NLR.
a
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Figure. Receiver operating characteristic curves of IL-8, CRP, NLR, combined marker, and CA-125 for differential
diagnosis between patients with endometriosis and controls.
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Table 4. The mean values of IL-8, NLR, CA-125, and the combined marker, and the differences in percentages of disease detection rates
of each parameter at various stages of endometriosis
NLR > 2.19

NLR

CA-125
> 29.9

CA-125
IU/mL

Combined
marker > 43.1

Combined
marker

IL-8 > 24

IL-8
pg/mL

Stage I
(n = 3)

2 (66.6%)

2.99
(2.24–3.92)

1 (33.3%)

57.13
(13.48–138)

1 (33.3%)

209.35
(30.15–541.39)

1 (33.3%)

23.13
(11.40–39.40)

Stage II
(n = 15)

9 (60.0%)

3.06
(1.26 – 6.31)

5 (33.3%)

38.10
(15.30–77.0)

11 (73.3%)

111.19
(26.94–237.71)

9 (60%)

71.07
(6.26–321.0)

Stage III
(n = 24)

20 (83.3%)

4.08
55.05
19 (79.19%)
(1.24–10.12)
(14.0–200.60)

22 (91.6%)

229.56
(37.38–175.34)

15 (62.5%)

741
(5.17–7500)

Stage IV
(n = 8)

7 (87.5%)

7.14
(3.36–11.49)

6 (75%)

480.17
(11.91–895.93)

6 (75%)

1143.81
(52.52–7500)

Stage I + II
(n = 18),
minimal to mild
endometriosis

11 (61.1%)a

3.05
41.27
6 (33.3%)a,b,c
(1.26–6.31)
(13.48–138.0)

12 (66.6%)b

Stage III + IV
(n = 32),
moderate to severe
endometriosis

27 (84.3%)

4.85
(1.24–11.49)

28 (87.5%)d

292.21
21 (65.6%)d
(37.38–1750.349)

842.34
(5.17–7500)

All stages
(n = 50)

38 (76.0%)

53.53
4.20
32 (64.0%)e
(13.48–200.6)
(1.24–11.49)

40 (80.0%)e,f

232.94
31 (62.0%)f
(26.94–1750.34)

561.81
(5.17–7500)

7 (87.5%)

26 (81.2%)

76.56
(19.40–193.40)

60.43
(14–200.60)

127.55
63.08
10 (55.5%)c
(26.94–541.39)
(6.26–321.0)

a,b,c,d,e,f: Values with different subscripts are significantly different at <0.05 by chi-square test.
Data are expressed as mean (95% confidence interval) or number of patients with percentages in parentheses.
NLR: Neutrophil-to-lymphocyte ratio, Combined marker: serum CA-125 levels multiplied by NLR.

markers gave improved sensitivity (69.3%) over either
test alone, but showed slightly reduced specificity (83.9%)
compared with CA-125, with a cut-off value of 55.7.
Our study is the first prospective study undertaken
to investigate the usefulness of analysing serum IL-8
and CRP levels and NLR either alone or as adjuncts to
CA-125 by ROC analysis to diagnose endometriosis in
a well-defined patient population. The overall sensitivity
and specificity of the combined markers were 80.0% and
86.0%, respectively, when using a cut-off value of 43.1
for the detection of endometriosis. When compared to
serum CA-125 alone, the combined markers were elevated
in a higher percentage of patients in various stages of
endometriosis.
Our results also show that preoperative CA-125 and IL-8
levels and NLR increase with the stage of endometriosis.
The combined markers and the NLR showed a strong
positive correlation with the stages, but IL-8 showed
no significant correlation. There are conflicting reports
about IL-8 levels in different stages of endometriosis in
the literature. We found that patients with endometriosis
had significantly higher levels of serum IL-8 than control
patients. By using a serum IL-8 cut-off point of 24, we were
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able to detect endometriosis cases with 62.0% sensitivity
and 73.0% specificity. The results from other studies have
been conflicting (25,26).
Only a few contradictory reports have been published
about CRP levels in endometriosis. Some studies have
reported increased levels of CRP in women with stage III
and IV endometriosis. However, Lermann et al. found
no statistically significant differences between the serum
CRP and high-sensitivity CRP (hsCRP) levels of patients
with endometriosis and healthy controls, similar to our
findings. They also found no association between hsCRP
or CRP levels and the stage of the disease. The diagnostic
performance of hsCRP was recently found to be superior
to classical CRP for women with moderate to severe
endometriosis. However, CRP was not found to be useful
for diagnosing the early stages of endometriosis (27,28).
In the present study, we found that neutrophilia
accompanied by a relative lymphocytopenia yielded an
increased NLR in patients with endometriosis, and the
data generated in our study show that a combination of
putative inflammatory markers and CA-125 could serve as
a multiple-marker screening test for endometriosis.
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